Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed
AUTOR(ES)
Bertino, Pietro
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117287Documentos Relacionados
- Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
- Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
- Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
- Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia
- Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance